Get this product for free
Submit your validation data for this product and get a full refund. I want to validate this product
General |
|
---|---|
Antigen | V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) Antibodies |
Epitope | C-Term Alternatives |
Reactivity | Human, Mouse (Murine), Rat (Rattus), Xenopus laevis Alternatives |
Host | Rabbit Alternatives |
Clonality | |
Conjugate | This AKT antibody is un-conjugated Alternatives |
Application |
ELISA, Western Blotting (WB)
Alternatives
|
Supplier | Log in to see |
Product Details anti-AKT AntibodyTarget Details AKT Application Details Handling Images |
|
Blocking Peptide | Blocking peptide for this product available: ABIN1607121 |
Specificity | This antibody may cross-react with AKT1, 2 and 3. |
Cross-Reactivity | Mouse (Murine), Rat (Rattus), Xenopus laevis |
Purification | Antibody was purified by Protein-G affinity chromatography. |
Immunogen | KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human AKT. |
Target Details AKTProduct Details anti-AKT Antibody Application Details Handling Images back to top |
|
Antigen | |
Alternative Name | AKT (AKT1 Antibody Abstract) |
Background |
Alternate Names: RAC-alpha serine/threonine-protein kinase, RAC-PK-alpha, Protein kinase B, PKB, C-AKT, AKT1, RAC Description: RAC-alpha serine/threonine-protein kinase (AKT1) signals downstream of phosphatidylinositol 3-kinase (PI3K) to mediate the effects of various growth factors such as PDGF, EGF, and IGF-I. This antibody may cross-react with AKT1, 2 and 3. |
NCBI Accession | NP_005154 |
UniProt | P31749 |
Pathways | PI3K-Akt Signaling, RTK Signaling, TCR Signaling, AMPK Signaling, Interferon-gamma Pathway, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Water Deprivation, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Negative Regulation of intrinsic apoptotic Signaling, Thromboxane A2 Receptor Signaling, Signaling of Hepatocyte Growth Factor Receptor, Positive Regulation of fat Cell Differentiation, VEGFR1 Specific Signals, VEGF Signaling |
Application DetailsProduct Details anti-AKT Antibody Target Details AKT Handling Images back to top |
|
Application Notes | E: 1:500-1:1,000, WB: 1:100-1:500 |
Restrictions | For Research Use only |
HandlingProduct Details anti-AKT Antibody Target Details AKT Application Details Images back to top |
|
Format | Liquid |
Concentration | 1 mg/mL |
Buffer | Each vial contains 0.1 mg IgG in 0.1 mL (1 mg/mL) of PBS pH 7.4 with 0.09 % sodium azide. |
Preservative | Sodium azide |
Precaution of Use | Warning: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. |
Handling Advice | Minimize freeze-thaw cycles. |
Storage | -20 °C |
Storage Comment | Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment. |
Expiry Date | 12 months |